Skip to main content
. 2023 Nov 22;11(48):16935–16945. doi: 10.1021/acssuschemeng.3c04183

Table 1. Literature Overview of Synthesis Protocols for the Erlotinib Intermediate 13.

no. Catalyst Ligand, cocatalyst Base, solvent Conditions X Yield (%) Scale (dm3)
155 Pd(CH3CN)2Cl2 (2 mol %) sSPhos (6 mol %), - TMG, HEP:H2O 1 M, 353 K, 10 h Br 92 0.05
222 Pd(OAc)2 (3 mol %) P(o-tol)3 (6 mol %), - DBU, THF 1 M, 353 K, 6 h Br 86 0.05
356,a 10 wt % Pd/C (2 mol %) PPh3 (8 mol %), CuI (4 mol %) DME:H2O, K2CO3 0.3 M, 353 K, 16 h I 78 0.1
468 Pd(DPPF)Cl2 (2 mol %) - TMG, HEP 0.5 M, 333 K, 3 h Br 99 0.05
552,b PdCl2 (0.6 mol %) PPh3 (2.4 mol %), CuCl2 (0.2 mol %) TMG, DMF 1 M, 348 K Br 73 0.1
653 Pd(OAc)2 (0.3 mol %) PPh3 (3.3 mol %), CuI (0.6 mol %) NEt3, - 1 M, 373 K, 7 h Br 75 2
7c Pd1@NC (0.3 mol %) PPh3 (1.5 mol %), CuI (6 mol %) MeCN, NEt3 1 M, 353 K, 3 h I 49 2
a

Stability and recyclability were not assessed.

b

Reaction time not specified.

c

This work.